Funds › Monashee Investment Management LLC
Monashee Investment Management LLC
13F for Q3 2026, filed Nov 6, 2026. 16 positions worth $33.4M.Managers with more than $100 million in US-listed stocks list their holdings each quarter, within 45 days of quarter end. Long positions only: no short sales or cash.
Ask your AI about this
Connect Claude, ChatGPT, Gemini or Grok (Microsoft 365 Copilot coming soon) to 13F.ai and ask in plain English. Copy a question to get started:
Using 13F.ai, what are the biggest new, added, trimmed and exited positions of Monashee Investment Management LLC in the latest 13F quarter?
Using 13F.ai, how has Monashee Investment Management LLC's portfolio concentration changed over the last four quarters?
Using 13F.ai, which of Monashee Investment Management LLC's top holdings have also been bought by insiders recently?
Connect your AI · Plans and the 7-day free trial (card required)
Holdings, Q3 2026
Largest first. Common shares only.
| # | The fund's own figures at the end of the quarter. A report can be up to 45 days old when it is filed. Options and bonds are not counted here. | Filing | ||||
|---|---|---|---|---|---|---|
| 1 | Axon Enterprise Inc Note 9/1 | 5.00M | $4.9M | 14.8% | New | 13F ↗ |
| 2 | IMMX Immix Biopharma, Inc. | 450,000 | $4.7M | 14.0% | New | 13F ↗ |
| 3 | SYY Sysco Corporation | 55,000 | $4.3M | 12.8% | New | 13F ↗ |
| 4 | NWCL newcleo plc | 400,000 | $3.1M | 9.4% | New | 13F ↗ |
| 5 | ADT ADT Inc. | 500,000 | $3.0M | 9.1% | -16.7% | 13F ↗ |
| 6 | SLDB Solid Biosciences Inc. | 410,000 | $3.0M | 8.9% | -18.0% | 13F ↗ |
| 7 | ENB Enbridge Inc | 50,000 | $2.3M | 7.0% | New | 13F ↗ |
| 8 | Viking Therapeutics Inc Note 2.000%10/1 | 1.50M | $1.5M | 4.6% | New | 13F ↗ |
| 9 | BLSM BlossomHill Therapeutics, Inc. | 80,000 | $1.5M | 4.5% | New | 13F ↗ |
| 10 | ETRA Electra Therapeutics, Inc. | 100,000 | $1.1M | 3.4% | New | 13F ↗ |
| 11 | YARW Yarrow Bioscience, Inc. | 40,000 | $900.8K | 2.7% | New | 13F ↗ |
| 12 | IMA ImageneBio, Inc. | 177,094 | $811.1K | 2.4% | -7.9% | 13F ↗ |
| 13 | AVAH Aveanna Healthcare Holdings Inc. | 50,000 | $620.5K | 1.9% | New | 13F ↗ |
| 14 | PYXS Pyxis Oncology, Inc. | 229,310 | $534.3K | 1.6% | New | 13F ↗ |
| 15 | OIG Orion180 Insurance Group Inc. | 55,000 | $530.2K | 1.6% | New | 13F ↗ |
| 16 | HGTY Hagerty, Inc. | 35,000 | $471.1K | 1.4% | New | 13F ↗ |
Changes since Q2 2026
13 new, 0 added to, 3 trimmed, 17 exited, 0 unchanged. By estimated dollars.
New positions (13)
| Axon Enterprise Inc Note 9/1 | 5.00M | New | $4.9M |
| IMMX Immix Biopharma, Inc. | 450,000 | New | $4.7M |
| SYY Sysco Corporation | 55,000 | New | $4.3M |
| NWCL newcleo plc | 400,000 | New | $3.1M |
| ENB Enbridge Inc | 50,000 | New | $2.3M |
| Viking Therapeutics Inc Note 2.000%10/1 | 1.50M | New | $1.5M |
| BLSM BlossomHill Therapeutics, Inc. | 80,000 | New | $1.5M |
| ETRA Electra Therapeutics, Inc. | 100,000 | New | $1.1M |
| YARW Yarrow Bioscience, Inc. | 40,000 | New | $900.8K |
| AVAH Aveanna Healthcare Holdings Inc. | 50,000 | New | $620.5K |
Added to (0)
None this quarter.
Trimmed (3)
Exited (17)
| Alphabet Inc Dep Shs RP1/20 A | 100,000 | Exited | -$5.1M |
| Alphabet Inc Dep Shs RP1/20 B | 100,000 | Exited | -$5.0M |
| DLR Digital Realty Trust, Inc. | 25,000 | Exited | -$4.5M |
| SYRE Spyre Therapeutics, Inc. | 50,000 | Exited | -$4.4M |
| TNGX Tango Therapeutics, Inc. | 100,000 | Exited | -$3.1M |
| Super Micro Computer Inc 7 Dep Cm Sr A Wi | 50,000 | Exited | -$2.6M |
| LEGN Legend Biotech Corporation · ADR | 85,385 | Exited | -$2.5M |
| GOOGL Alphabet Inc. Class A | 6,000 | Exited | -$2.1M |
| GOOG Alphabet Inc. Class C | 6,000 | Exited | -$2.1M |
| QURE uniQure N.V. | 45,000 | Exited | -$2.1M |
The 10 largest of each, by estimated dollars: shares changed times the later report's price. Index tracking, splits and mergers move positions too.
Compare two quarters
Pick any two quarters: what is new, added to, trimmed or exited. Premium plan.
Reported value by quarter
Value and number of positions at the end of each quarter.
Loading…
Largest positions in earlier quarters
Pick a quarter to see what the fund's biggest positions were then.
Loading…
Ten largest positions
By value, Q3 2026.
Filings
| Filing | ||||||
|---|---|---|---|---|---|---|
| Q3 2026 | Nov 6, 2026 | 13F-HR | 16 | $33.4M | Current | SEC ↗ |
| Q2 2026 | Aug 13, 2026 | 13F-HR | 23 | $59.6M | Current | SEC ↗ |
| Q1 2026 | May 13, 2026 | 13F-HR | 45 | $183.8M | Current | SEC ↗ |
| Q4 2025 | Feb 12, 2026 | 13F-HR | 40 | $177.5M | Current | SEC ↗ |
| Q3 2025 | Nov 12, 2025 | 13F-HR | 61 | $200.5M | Current | SEC ↗ |
| Q2 2025 | Aug 11, 2025 | 13F-HR | 57 | $275.9M | Current | SEC ↗ |
| Q1 2025 | May 14, 2025 | 13F-HR | 46 | $845.1M | Current | SEC ↗ |
Most recent first, up to 80. An amendment can replace a report or add holdings to it. All 13F filings
Information, not investment advice. Values are the fund's own figures at quarter end; a report can be up to 45 days old when filed. Disclaimer